Malik D, Rath T, Urcuyo Acevedo J, Canoll P, Swanson K, Boxerman J
Front Radiol. 2023; 2:809373.
PMID: 37492687
PMC: 10365126.
DOI: 10.3389/fradi.2022.809373.
Ozturk K, Soylu E, Cayci Z
Neuroradiology. 2021; 63(11):1801-1810.
PMID: 33738509
DOI: 10.1007/s00234-021-02674-2.
Viselner G, Farina L, Lucev F, Turpini E, Lungarotti L, Bacila A
Insights Imaging. 2019; 10(1):94.
PMID: 31549243
PMC: 6757093.
DOI: 10.1186/s13244-019-0784-9.
Schmainda K, Prah M, Hu L, Quarles C, Semmineh N, Rand S
AJNR Am J Neuroradiol. 2019; 40(4):626-633.
PMID: 30923088
PMC: 6461489.
DOI: 10.3174/ajnr.A6015.
Park I, Lupo J, Nelson S
Mol Imaging Biol. 2018; 21(4):626-632.
PMID: 30225760
PMC: 8172073.
DOI: 10.1007/s11307-018-1275-y.
Investigating tumor perfusion by hyperpolarized C MRI with comparison to conventional gadolinium contrast-enhanced MRI and pathology in orthotopic human GBM xenografts.
Park I, von Morze C, Lupo J, Ardenkjaer-Larsen J, Kadambi A, Vigneron D
Magn Reson Med. 2016; 77(2):841-847.
PMID: 26892398
PMC: 4991955.
DOI: 10.1002/mrm.26155.
Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification.
Gupta A, Young R, Shah A, Schweitzer A, Graber J, Shi W
Clin Neuroradiol. 2014; 25(2):143-50.
PMID: 24474262
PMC: 4712066.
DOI: 10.1007/s00062-014-0289-3.
Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma.
LaViolette P, Daun M, Paulson E, Schmainda K
J Neurooncol. 2013; 116(3):543-549.
PMID: 24293201
PMC: 4316680.
DOI: 10.1007/s11060-013-1318-9.
Perfusion MRI: the five most frequently asked clinical questions.
Essig M, Nguyen T, Shiroishi M, Saake M, Provenzale J, Enterline D
AJR Am J Roentgenol. 2013; 201(3):W495-510.
PMID: 23971482
PMC: 3842445.
DOI: 10.2214/AJR.12.9544.
The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications.
Boxerman J, Paulson E, Prah M, Schmainda K
AJNR Am J Neuroradiol. 2013; 34(7):1364-9.
PMID: 23413249
PMC: 4316677.
DOI: 10.3174/ajnr.A3477.
Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.
Verma N, Cowperthwaite M, Burnett M, Markey M
Neuro Oncol. 2013; 15(5):515-34.
PMID: 23325863
PMC: 3635510.
DOI: 10.1093/neuonc/nos307.
Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM.
Essock-Burns E, Phillips J, Molinaro A, Lupo J, Cha S, Chang S
J Magn Reson Imaging. 2013; 38(2):388-400.
PMID: 23281184
PMC: 3711964.
DOI: 10.1002/jmri.23982.
Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients.
Hatzoglou V, Ulaner G, Zhang Z, Beal K, Holodny A, Young R
Clin Imaging. 2012; 37(3):451-7.
PMID: 23068052
PMC: 3789370.
DOI: 10.1016/j.clinimag.2012.08.008.
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.
Barajas Jr R, Phillips J, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G
Neuro Oncol. 2012; 14(7):942-54.
PMID: 22711606
PMC: 3379808.
DOI: 10.1093/neuonc/nos128.
Diffusion-weighted MRI, dynamic susceptibility contrast MRI and ultrasound perfusion quantification of denervated muscle in rabbits.
Goyault G, Bierry G, Holl N, Lhermitte B, Dietemann J, Beregi J
Skeletal Radiol. 2011; 41(1):33-40.
PMID: 21308468
DOI: 10.1007/s00256-011-1108-4.
Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.
Barajas Jr R, Hodgson J, Chang J, VandenBerg S, Yeh R, Parsa A
Radiology. 2010; 254(2):564-76.
PMID: 20093527
PMC: 2809924.
DOI: 10.1148/radiol.09090663.
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Barajas Jr R, Chang J, Segal M, Parsa A, McDermott M, Berger M
Radiology. 2009; 253(2):486-96.
PMID: 19789240
PMC: 2770116.
DOI: 10.1148/radiol.2532090007.
Perfusion imaging of the right perisylvian neural network in acute spatial neglect.
Zopf R, Berger M, Klose U, Karnath H
Front Hum Neurosci. 2009; 3:15.
PMID: 19680470
PMC: 2726039.
DOI: 10.3389/neuro.09.015.2009.
Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.
Kapoor G, Gocke T, Chawla S, Whitmore R, Nabavizadeh A, Krejza J
J Neurooncol. 2009; 92(3):373-86.
PMID: 19357963
DOI: 10.1007/s11060-009-9880-x.
Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Barajas R, Chang J, Sneed P, Segal M, McDermott M, Cha S
AJNR Am J Neuroradiol. 2008; 30(2):367-72.
PMID: 19022867
PMC: 7051401.
DOI: 10.3174/ajnr.A1362.